0001398659-22-000005.txt : 20220211 0001398659-22-000005.hdr.sgml : 20220211 20220211070519 ACCESSION NUMBER: 0001398659-22-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220211 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 22616670 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 8-K 1 g-20220211.htm 8-K g-20220211
0001398659FALSE00013986592022-02-112022-02-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 11, 2022
GENPACT LIMITED
(Exact name of registrant as specified in its charter)
Bermuda     001-3362698-0533350
(State or other jurisdiction
of incorporation)
   (Commission
     File Number)
(I.R.S. Employer
Identification No.)
Canon's Court, 22 Victoria Street
Hamilton HM 12, Bermuda
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (441298-3300
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading SymbolName of each exchange on which registered
Common shares, par value $0.01 per shareGNew York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02Results of Operations and Financial Condition.
On February 11, 2022, Genpact Limited (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2021.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.Financial Statements and Exhibits.
(d)Exhibits:
 
Exhibit 99.1  
Exhibit 104 
Cover Page Interactive Data File (embedded within the Inline XBRL document)



Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  GENPACT LIMITED
     
Date: February 11, 2022 By: /s/ Heather D. White
  Name: Heather D. White
  Title: Senior Vice President, Chief Legal Officer and Secretary

EX-99.1 2 genpactltdexhibit9911.htm EX-99.1 Document

Exhibit 99.1
image.jpg
Genpact Reports Full Year and Fourth Quarter 2021 Results
2021 Total Revenue of $4.0 billion, Up 8% (7% on a constant currency basis)1
2021 Global Client Revenue of $3.6 billion, Up 12% (11% on a constant currency basis)1, 2
2021 Diluted EPS of $1.91, Up 22%; Adjusted Diluted EPS3 of $2.45, Up 16%
Quarterly Cash Dividend Increased by 16%

NEW YORK, February 11, 2022 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the fourth quarter and full year ended December 31, 2021.
“We are very pleased with our full year 2021 financial results with revenue, adjusted diluted EPS and cash flow ahead of our expectations. We continued to strategically invest for long-term growth while meaningfully expanding our adjusted operating income margin,” said “Tiger” Tyagarajan, Genpact’s president and CEO. “For the fourth consecutive year our analytics, digital, and consulting businesses, which make up Transformation Services, led our Global Client growth. Our bookings accelerated during 2021, increasing 20% year-over-year. We are very excited about winning 97 new logos during the year that provide great opportunities to expand these relationships. Our attrition stabilized during the fourth quarter. We are proud of our talent management practices and ability to hire at scale.”

Key Financial Highlights – Full Year 2021
Total revenue was $4.0 billion, up 8% year-over-year (7% on a constant currency basis).1
Revenue from Global Clients was $3.6 billion, up 12%2 year-over-year (11% on a constant currency basis),1, 2 representing 91% of total revenue, including $39 million of revenue from certain GE-divested businesses that is now included in Global Client revenue. Excluding the revenue from such GE-divested businesses, revenue from Global Clients increased 11% year over year (10% on a constant currency basis).1
Revenue from GE businesses was $376 million, down 18% year-over-year, representing 9% of total revenue. This excludes $39 million of revenue from certain GE-divested businesses that is now included as Global Client revenue. If the revenue from these GE-divested businesses had been counted as GE revenue in the full year of 2021, revenue from GE businesses would have decreased 10% year-over-year.
Net income was $369 million, up 20% year-over-year, with a corresponding margin of 9.2%.
Diluted earnings per share was $1.91, up 22% year-over-year, and adjusted diluted earnings per share3 was $2.45, up 16% year-over-year.
Income from operations was $509 million, up 16% year-over-year, with a corresponding margin of 12.7%. Adjusted income from operations was $663 million, up 13% year-over-year, with a corresponding margin of 16.5%.4
New bookings were approximately $3.7 billion, up 20% year-over-year.5
1 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.
2 Global Client revenue for the fourth quarter and year ended 2021 includes revenue from certain businesses divested by GE that we continue to serve as Global Clients. Revenue from such businesses has been counted as Global Client revenue beginning January 1, 2021.
3 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
4 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income to adjusted income from operations and GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin are attached to this release.
5 New bookings, an operating measure, represents the total contract value of new contracts and certain renewals, extensions and changes to existing contracts. Regular renewals of contracts with no change in scope are not counted as new bookings.





Cash generated from operations was $694 million, up 19% from $584 million in 2020.
Genpact repurchased approximately 6.6 million of its common shares for total consideration of approximately $298 million at an average price per share of $45.32.

Key Financial Highlights – Fourth Quarter 2021
Total revenue was $1.1 billion, up 13% year-over-year, both on an as reported and constant currency basis.1
Revenue from Global Clients was $979 million, up 16% year-over-year, both on an as reported and constant currency basis,1 representing 91% of total revenue, including $9 million of revenue from certain GE-divested businesses that is now included in Global Client revenue. Excluding the revenue from such GE-divested businesses, revenue from Global Clients increased 15% year-over-year both on an as reported and constant currency basis.1
Revenue from GE businesses was $93 million, down 14% year-over-year, representing 9% of total revenue. This excludes $9 million of revenue from certain GE-divested businesses that is now included as Global Client revenue. If the revenue from these GE-divested businesses had been counted as GE revenue in the fourth quarter of 2021, revenue from GE businesses would have declined 6% year-over-year.
Net income was $73 million, down 3% year-over-year, with a corresponding margin of 6.8%.
Diluted earnings per share was $0.38, flat year-over-year, and adjusted diluted earnings per share3 was $0.54, up 6% year-over-year.
Income from operations was $112 million, down 1% year-over-year, with a corresponding margin of 10.4%. Adjusted income from operations was $154 million, up 4% year-over-year, with a corresponding margin of 14.4%.4
Cash generated from operations was $247 million, up 55% from $159 million in the fourth quarter of 2020.
Genpact repurchased approximately 2.98 million of its common shares during the quarter for total consideration of approximately $151 million at an average price per share of $50.56.

Capital Allocation
Genpact’s Board of Directors declared a quarterly cash dividend for the first quarter of 2022 of $0.125, a 16% increase, payable on March 23, 2022 to shareholders of record as of the close of business on March 10, 2022. This represents a planned annual dividend of $0.50 per common share, increased from $0.43 per common share in 2021.

Full Year 2022 Outlook
Genpact expects:
Total revenue of $4.3 billion to $4.4 billion, up 7.0% to 9.0%, or 8.0% to 10.0% on a constant currency basis.1
Global Client revenue growth in the range of 8.0% to 11.0%, or 9.0% to 12.0% on a constant currency basis.1
Adjusted income from operations margin6 of 16.0% to 16.5%.
Adjusted diluted EPS7 of $2.53 to $2.71.

Conference Call to Discuss Financial Results
Genpact’s management will host an hour-long conference call beginning at 8:00 a.m. ET on February 11, 2022 to discuss the company’s performance for the fourth quarter and full year ended December 31, 2021. To participate, callers can dial +1 (877) 654-0173 from within the U.S. or +1 (281) 973-6289 from any other country. Callers will be prompted to enter the conference ID, 4953356. A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the Genpact website after the end of the call. A transcript of the call will also be made available on the website.

6 Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin is attached to this release.
7Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.




About Genpact
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. Led by our purpose -- the relentless pursuit of a world that works better for people -- we drive digital-led innovation and digitally enabled intelligent operations for our clients. Guided by our experience reinventing and running thousands of processes for hundreds of clients, many of them Global Fortune 500 companies, we drive real-world transformation at scale. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 100,000+ of us. From New York to New Delhi, and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent the ways companies work. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we’ll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here.
Safe Harbor
This press release contains certain statements concerning our future growth prospects, including our outlook for 2022, financial results and other forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements. These risks, uncertainties, and other factors include but are not limited to the impact of the COVID-19 pandemic on our business and on our employees, clients, partners and suppliers, our ability to attract and retain skilled professionals, a slowdown in the economies and sectors in which our clients operate, a slowdown in the business process outsourcing or information technology services sectors, our ability to develop and successfully execute our business strategies, the risks and uncertainties arising from our past and future acquisitions, our ability to convert bookings to revenues, our ability to manage growth, factors which may impact our cost advantage, wage increases, changes in tax rates and tax legislation and other laws and regulations, risks and uncertainties regarding fluctuations in our earnings, foreign currency fluctuations, general economic conditions affecting our industry, political, economic or business conditions in countries in which we operate, including the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, as well as other risks detailed in our reports filed with the U.S. Securities and Exchange Commission, including Genpact's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available at www.sec.gov. Genpact may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. Although Genpact believes that these forward-looking statements are based on reasonable assumptions, you are cautioned not to put undue reliance on these forward-looking statements, which reflect management's current analysis of future events and should not be relied upon as representing management's expectations or beliefs as of any date subsequent to the time they are made. Genpact undertakes no obligation to update any forward-looking statements that may be made from time to time by or on behalf of Genpact.

Contacts
 
Investors  Roger Sachs, CFA
  
+1 (203) 808-6725
  
roger.sachs@genpact.com
Media  
Siya Belliappa
+1 (718) 561-9843
siya.belliappa@genpact.com



GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets
(Unaudited)
(In thousands, except per share data and share count)


As of December 31, 2020As of December 31, 2021
Assets
Current assets
Cash and cash equivalents$680,440$899,458
Accounts receivable, net of allowance for credit losses of $27,707 and $24,329 as of December 31, 2020 and 2021, respectively881,020
887,742
Prepaid expenses and other current assets187,408134,441
Total current assets$1,748,868$1,921,641


Property, plant and equipment, net231,122 215,089
Operating lease right-of-use assets304,714 
270,603 
Deferred tax assets106,674 106,322 
Intangible assets, net236,732 169,635 
Goodwill1,695,688 1,731,027
Contract cost assets225,897 238,794 
Other assets, net of allowance for credit losses of $3,134 and $3,711 as of December 31, 2020 and 2021, respectively323,818 322,158
Total assets$4,873,513$4,975,269
Liabilities and equity
Current liabilities
Short-term borrowings$250,000$
Current portion of long-term debt33,537 383,433 
Accounts payable13,910 24,984 
Income taxes payable41,941 47,353 
Accrued expenses and other current liabilities806,769 791,440 
Operating leases liability56,479 61,591 
Total current liabilities$1,202,636$1,308,801
Long-term debt, less current portion1,307,371 1,272,476 
Operating leases liability289,363 247,707 
Deferred tax liabilities1,516 3,942
Other liabilities238,398 245,210 
Total liabilities$3,039,284$3,078,136
Shareholders' equity
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued
Common shares, $0.01 par value, 500,000,000 authorized, 189,045,661 and 185,336,357 issued and outstanding as of December 31, 2020 and 2021, respectively1,8851,847
Additional paid-in capital1,636,0261,717,165
Retained earnings741,658732,474
Accumulated other comprehensive income (loss)(545,340)(554,353)
Total equity$1,834,229$1,897,133
Total liabilities and equity$4,873,513$4,975,269





GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income
(Unaudited)
(In thousands, except per share data and share count)


Three months ended December 31,
201920202021
Net revenues$940,739 $950,568$1,072,277
Cost of revenue630,648 613,645702,656
Gross profit$310,091 $336,923$369,621
Operating expenses:
Selling, general and administrative expenses212,650 207,860 244,858 
Amortization of acquired intangible assets9,047 11,670 13,824 
Other operating (income) expense, net(31,124)4,340 (986)
Income from operations$119,518 $113,053$111,925
Foreign exchange gains (losses), net4,083 (4,129)1,140 
Interest income (expense), net(9,971)(10,888)(13,236)
Other income (expense), net719 2,292 3,929 
Income before income tax expense$114,349 $100,328$103,758
Income tax expense32,151 25,34630,673
Net income$82,198$74,982$73,085
Earnings per common share
Basic$0.43$0.40$0.39 
Diluted$0.42$0.38$0.38 
Weighted average number of common shares used in computing earnings per common share
Basic190,083,647 189,470,107 187,373,174 
Diluted196,592,325 194,823,683 193,191,605 




GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income
(Unaudited)
(In thousands, except per share data and share count)
Year ended December 31,
201920202021
Net revenues$3,520,543 $3,709,377$4,022,211
Cost of revenue2,294,688 2,418,1372,590,252
Gross profit$1,225,855 $1,291,240$1,431,959
Operating expenses:
Selling, general and administrative expenses794,901 789,849 865,715 
Amortization of acquired intangible assets32,612 43,343 58,448 
Other operating (income) expense, net(31,034)19,331 (1,203)
Income from operations$429,376 $438,717$508,999
Foreign exchange gains (losses), net7,729 7,482 12,669 
Interest income (expense), net(43,458)(48,960)(51,434)
Other income (expense), net5,786 3,238 12,895 
Income before equity-method investment activity, net and income tax expense
$399,433 $400,477$483,129
Equity-method investment activity, net
(16)
Income before income tax expense
$399,417 $400,477$483,129
Income tax expense94,536 92,201113,681
Net income$304,881$308,276$369,448
Earnings per common share
Basic$1.60$1.62$1.97 
Diluted$1.56$1.57$1.91 
Weighted average number of common shares used in computing earnings per common share
Basic190,074,475 190,396,780 187,802,219 
Diluted195,160,855 195,780,971 192,961,841 



GENPACT LIMITED AND ITS SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)(In thousands)
Year ended December 31,
201920202021
Operating activities
Net income$304,881 $308,276 $369,448 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization96,101 116,499 109,124 
Amortization of debt issuance costs(including loss on extinguishment of debt)1,779 2,248 2,678 
Amortization of acquired intangible assets32,612 43,343 58,448 
Write-down of intangible assets and property, plant and equipment3,511 14,083 915 
Reserve for doubtful receivables/ allowance for credit losses7,443 5,707 1,487 
Unrealized loss (gain) on revaluation of foreign currency asset/liability(5,171)9,578 (8,304)
Stock-based compensation expense83,885 74,008 81,968 
Deferred tax benefit(16,315)(22,587)(9,263)
Write-down of operating lease right-of-use assets and other assets— 18,084 — 
Gain on exchange of non-monetary asset
(31,380)— — 
Others, net(2,213)(1,291)623 
Change in operating assets and liabilities:
(Increase) decrease in accounts receivable(121,983)42,505 (11,803)
(Increase) decrease in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets(69,813)(99,852)83,432 
Increase (decrease) in accounts payable(21,375)(12,480)11,740 
Increase (decrease) in accrued expenses, other current liabilities, operating lease liabilities and other liabilities157,580 87,180 (2,057)
Increase (decrease) in income taxes payable8,346 (993)5,845 
Net cash provided by operating activities$427,888 $584,308 $694,281 
Investing activities
Purchase of property, plant and equipment(74,927)(70,170)(53,341)
Payment for internally generated intangible assets (including intangibles under development)(33,834)(10,201)(3,907)
Proceeds from sale of property, plant and equipment and intangibles assets1,750 607 6,384 
Proceeds from sale of equity affiliates2,168 — — 
Payment for business acquisitions, net of cash acquired(252,276)(186,633)(72,025)
Proceed from sale of investment— — 142 
Net cash (used for) investing activities$(357,119)$(266,397)$(122,747)
Financing activities
Repayment of finance lease obligations(7,380)(10,567)(13,926)
Payment of debt issuance costs(2,317)(620)(3,029)
Proceeds from long-term debt400,000 — 350,000 
Repayment of long-term debt(34,000)(34,000)(34,002)
Proceeds from short-term borrowings400,000 610,000 — 
Repayment of short-term borrowings(625,000)(430,000)(250,000)
Proceeds from issuance of common shares under stock-based compensation plans19,670 25,135 35,051 
Payment for net settlement of stock-based awards(3,850)(34,083)(35,717)
Payment of earn-out consideration(12,790)(6,552)(2,556)
Dividend paid(64,671)(74,212)(80,479)
Payment for stock repurchased and retired (including expenses related to stock repurchase)(30,015)(137,112)(298,219)
Others— (6)
Net cash provided by (used for) financing activities$39,647 $(92,011)$(332,883)
Effect of exchange rate changes(11,716)(12,556)(19,663)
Net increase in cash and cash equivalents110,416 225,900 238,651 
Cash and cash equivalents at the beginning of the period368,396 467,096 680,440 
Cash and cash equivalents at the end of the period$467,096 $680,440 $899,458 
Supplementary information
Cash paid during the period for interest (including interest rate swaps)$45,084 $49,101 $46,348 
Cash paid during the period for income taxes, net of refunds$104,217 $193,946 $31,761 
Property, plant and equipment acquired under finance lease obligations
$5,008 $29,526 $286 
Non-cash transaction: Gain on exchange of non-monetary asset
$(31,380)$— $— 



Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:
Adjusted income from operations;
Adjusted income from operations margin;
Adjusted diluted earnings per share; and
Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact’s GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.
Prior to July 2012, Genpact’s management used financial statements that excluded significant acquisition-related expenses, amortization of related acquired intangibles, and amortization of acquired intangibles recorded at the company’s formation in 2004 for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to that of its competitors. However, considering Genpact’s acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact’s management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to those of its competitors. For the same reasons, since April 2016 Genpact’s management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated.
Genpact’s management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 “Compensation-Stock Compensation,” Genpact’s management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact’s operating results and those of other companies. As a result of the COVID-19 pandemic, during the second and third quarters of 2020 the Company initiated several restructuring measures. In connection with the restructuring, the Company recorded non-recurring charges related to the following: i) right-of-use lease assets and other assets related to certain abandoned leased office properties in the second quarter of 2020 and ii) employee severance costs related to a focused reduction in Genpact's workforce in the second and third quarters of 2020. Genpact's management believes that excluding such charges provides useful information to both management and investors regarding the Company's financial performance and underlying business trends. Additionally, in its calculations of non-GAAP financial measures, Genpact’s management has adjusted foreign exchange gains and losses, interest income and expense and income tax expenses from GAAP net income, and other income and expenses, and certain gains, losses and impairment charges attributable to equity-method investments from GAAP income from operations, because management believes that the Company’s results after taking into account these adjustments more accurately reflect the Company’s ongoing operations. In its calculations of adjusted diluted earnings per share, Genpact’s management adds back adjusted stock-based compensation expense, amortization and impairment of acquired intangible assets, acquisition-related expenses and restructuring expenses and the related tax impact of such adjustments from GAAP diluted earnings per share. For the purpose of calculating adjusted diluted earnings per share, the combined current and deferred tax effect is determined by multiplying each pre-tax adjustment by the applicable statutory income tax rate.
Genpact’s management provides information about revenues on a constant currency basis so that the revenues may be viewed without the impact of foreign currency exchange rate fluctuations compared to prior fiscal periods, thereby facilitating period-to-period comparisons of the Company’s true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.
Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company’s reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.
A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income and net income margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation expense and amortization and impairment of acquired intangible assets. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.




The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months and years ended December 31, 2020 and 2021:
Reconciliation of Net income/Margin to Adjusted Income from Operations/Margin
(In thousands)

Three months ended December 31,Year ended December 31,
2020 2021 20202021
Net income$74,982$73,085$308,276$369,448
Foreign exchange (gains) losses, net4,129(1,140)(7,482)(12,669)
Interest (income) expense, net10,88813,23648,96051,434
Income tax expense25,34630,67392,201113,681
Stock-based compensation expense18,19023,36474,00881,968
Amortization and impairment of acquired intangible assets11,43013,66443,64857,641
Restructuring expenses26,547
Acquisition-related expenses2,6501,1772,6501,177
Adjusted income from operations$147,615$154,059$588,808$662,680
Net income margin7.9%6.8%8.3%9.2%
Adjusted income from operations margin15.5%14.4%15.9%16.5%
    
    
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin
(In thousands)

Three months ended December 31,Year ended December 31,
2020 2021 20202021
Income from operations$113,053$111,925$438,717$508,999
Stock-based compensation expense18,19023,36474,00881,968
Amortization and impairment of acquired intangible assets11,43013,66443,64857,641
Acquisition-related expenses2,6501,1772,6501,177
Other income (expense), net2,2923,9293,23812,895
Restructuring expenses26,547
Adjusted income from operations$147,615$154,059$588,808$662,680
Income from operations margin11.9%10.4%11.8%12.7%
Adjusted income from operations margin15.5%14.4%15.9%16.5%



Reconciliation of Diluted EPS to Adjusted Diluted EPS8
(Per share data) 

Three months ended December 31,Year ended December 31,
2020 202120202021
Diluted EPS$0.38 $0.38 $1.57  $1.91 
Stock-based compensation expense0.090.120.380.42
Amortization and impairment of acquired intangible assets0.060.070.220.30
Acquisition-related expenses0.010.010.010.01
Restructuring expenses— 0.14— 
Tax impact on stock-based compensation expense(0.03)(0.02)(0.11)(0.11)
Tax impact on amortization and impairment of acquired intangible assets(0.01)(0.01)(0.06)(0.07)
Tax impact on acquisition-related expenses(0.00)(0.00)(0.00)(0.00)
Tax impact on restructuring expenses— (0.03)— 
Adjusted diluted EPS$0.51$0.54$2.12 $2.45 
8 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.



The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending December 31, 2022:

Reconciliation of Outlook for Net income Margin to Adjusted Income from Operations Margin9


Year ending December 31, 2022
LowerUpper
Net income margin9.2%9.7%
Estimated interest (income) expense, net1.1%1.0%
Estimated income tax expense2.9%3.0%
Estimated stock-based compensation expense1.8%1.8%
Estimated amortization of acquired intangible assets1.0%1.0%
Adjusted income from operations margin16.0%16.5%



Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from Operations Margin9

Year ending December 31, 2022
LowerUpper
Income from operations margin13.1%13.6%
Estimated stock-based compensation expense1.8%1.8%
Estimated amortization and impairment of acquired intangible assets1.0%1.0%
Estimated other income (expense), net0.1%0.1%
Adjusted income from operations margin16.0%16.5%


Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS9
(Per share data)

Year ending December 31, 2022
LowerUpper
Diluted EPS$2.06$2.24
Estimated stock-based compensation expense0.410.41
Estimated amortization of acquired intangible assets0.230.23
Estimated tax impact on stock-based compensation expense(0.11)(0.11)
Estimated tax impact on amortization of acquired intangible assets(0.06)(0.06)
Adjusted diluted EPS$2.53 $2.71
9 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.

EX-101.SCH 3 g-20220211.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 g-20220211_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type Entity Address, Country Entity Address, Country City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 g-20220211_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image.jpg begin 644 image.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Feb. 11, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 11, 2022
Entity Registrant Name GENPACT LIMITED
Entity Incorporation, State or Country Code D0
Entity File Number 001-33626
Entity Tax Identification Number 98-0533350
Entity Address, Address Line One Canon's Court,
Entity Address, Address Line Two 22 Victoria Street
Entity Address, City or Town Hamilton
Entity Address, Postal Zip Code HM 12
Entity Address, Country BM
City Area Code 441
Local Phone Number 298-3300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares, par value $0.01 per share
Trading Symbol G
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001398659
Amendment Flag false
XML 8 g-20220211_htm.xml IDEA: XBRL DOCUMENT 0001398659 2022-02-11 2022-02-11 0001398659 false 8-K 2022-02-11 GENPACT LIMITED D0 001-33626 98-0533350 Canon's Court, 22 Victoria Street Hamilton HM 12 BM 441 298-3300 false false false false Common shares, par value $0.01 per share G NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 118 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.genpact.com/role/Cover Cover Cover 1 false false All Reports Book All Reports g-20220211.htm g-20220211.xsd g-20220211_lab.xml g-20220211_pre.xml genpactltdexhibit9911.htm http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g-20220211.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "g-20220211.htm" ] }, "labelLink": { "local": [ "g-20220211_lab.xml" ] }, "presentationLink": { "local": [ "g-20220211_pre.xml" ] }, "schema": { "local": [ "g-20220211.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "g", "nsuri": "http://www.genpact.com/20220211", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "g-20220211.htm", "contextRef": "id610bd518bb64a72bf103a0435196da3_D20220211-20220211", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.genpact.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "g-20220211.htm", "contextRef": "id610bd518bb64a72bf103a0435196da3_D20220211-20220211", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001398659-22-000005-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001398659-22-000005-xbrl.zip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